As of the latest Form 4 filed May 12, 2026.
What Amneal Pharmaceuticals, Inc. Class A Common Stock insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 65 most recent filings for AMRX.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | 2026-05-11 | Autor Deborah M. Director | SSale | −34.8K | $12.94 | $451K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | BUCHI J KEVIN Director | MExercise | +34.8K | — | — | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Autor Deborah M. Director | MExercise | +34.8K | — | — | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | George Jeffrey P. Director | MExercise | +34.8K | — | — | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Patel Gautam Director | MExercise | +34.8K | — | — | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Kiely John Director | MExercise | +34.8K | — | — | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Nark Ted C Director | MExercise | +34.8K | — | — | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | MEISTER PAUL M Director | MExercise | +48.7K | — | — | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Yanai Shlomo Director | MExercise | +34.8K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | Patel Chintu Co-CEO | FTax | −29.0K | $13.30 | $385K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | Patel Chintu, Co-CEO | MExercise | +92.6K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | Patel Chirag K. President & Co-CEO | FTax | −37.8K | $13.30 | $503K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | Patel Chirag K., President & Co-CEO | MExercise | +92.6K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | Daly Jason B. EVP, Chief Legal Officer | FTax | −15.6K | $13.30 | $207K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | Daly Jason B., EVP, Chief Legal Officer | MExercise | +35.9K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | Konidaris Tasos Executive Vice President & CFO | FTax | −22.0K | $13.30 | $293K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | Konidaris Tasos, Executive Vice President & CFO | MExercise | +44.0K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | BOYER ANDREW S Executive Vice President | FTax | −19.1K | $13.30 | $255K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | BOYER ANDREW S, Executive Vice President | MExercise | +38.2K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | Shah Nikita Executive Vice President | FTax | −18.0K | $13.30 | $239K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | Shah Nikita, Executive Vice President | MExercise | +35.9K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Patel Chintu Co-CEO | FTax | −316K | $13.31 | $4.20M | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Patel Chintu, Co-CEO | MExercise | +734K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Patel Chintu, Co-CEO | FTax | −17.1K | $13.31 | $228K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Patel Chintu, Co-CEO | MExercise | +59.9K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Patel Chirag K. President & Co-CEO | FTax | −298K | $13.31 | $3.96M | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Patel Chirag K., President & Co-CEO | MExercise | +734K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Patel Chirag K., President & Co-CEO | FTax | −15.6K | $13.31 | $208K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Patel Chirag K., President & Co-CEO | MExercise | +59.9K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Daly Jason B. EVP, Chief Legal Officer | FTax | −133K | $13.31 | $1.77M | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Daly Jason B., EVP, Chief Legal Officer | MExercise | +306K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Daly Jason B., EVP, Chief Legal Officer | FTax | −10.5K | $13.31 | $140K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Daly Jason B., EVP, Chief Legal Officer | MExercise | +24.3K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Daly Jason B., EVP, Chief Legal Officer | FTax | −16.6K | $13.31 | $221K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Daly Jason B., EVP, Chief Legal Officer | MExercise | +38.2K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Daly Jason B., EVP, Chief Legal Officer | FTax | −10.1K | $13.31 | $135K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Daly Jason B., EVP, Chief Legal Officer | MExercise | +22.6K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Konidaris Tasos Executive Vice President & CFO | FTax | −230K | $13.31 | $3.06M | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Konidaris Tasos, Executive Vice President & CFO | MExercise | +459K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Konidaris Tasos, Executive Vice President & CFO | FTax | −14.3K | $13.31 | $190K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Konidaris Tasos, Executive Vice President & CFO | MExercise | +28.5K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Konidaris Tasos, Executive Vice President & CFO | FTax | −24.3K | $13.31 | $323K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Konidaris Tasos, Executive Vice President & CFO | MExercise | +57.3K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Konidaris Tasos, Executive Vice President & CFO | FTax | −16.2K | $13.31 | $215K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Konidaris Tasos, Executive Vice President & CFO | MExercise | +45.3K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | BOYER ANDREW S Executive Vice President | FTax | −199K | $13.31 | $2.65M | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | BOYER ANDREW S, Executive Vice President | MExercise | +398K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | BOYER ANDREW S, Executive Vice President | FTax | −12.2K | $13.31 | $162K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | BOYER ANDREW S, Executive Vice President | MExercise | +24.3K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | BOYER ANDREW S, Executive Vice President | FTax | −24.9K | $13.31 | $331K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | BOYER ANDREW S, Executive Vice President | MExercise | +49.7K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | BOYER ANDREW S, Executive Vice President | FTax | −19.9K | $13.31 | $265K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | BOYER ANDREW S, Executive Vice President | MExercise | +39.3K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Shah Nikita Executive Vice President | FTax | −184K | $13.31 | $2.45M | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Shah Nikita, Executive Vice President | MExercise | +367K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Shah Nikita, Executive Vice President | FTax | −11.8K | $13.31 | $157K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Shah Nikita, Executive Vice President | MExercise | +23.5K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Shah Nikita, Executive Vice President | FTax | −23.0K | $13.31 | $306K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Shah Nikita, Executive Vice President | MExercise | +45.9K | — | — | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Shah Nikita, Executive Vice President | FTax | −18.5K | $13.31 | $246K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Shah Nikita, Executive Vice President | MExercise | +36.2K | — | — | No | Form 4 ↗ |
| 2025-11-19 | 2025-11-17 | Nark Ted C Director | SSale | −50.0K | $11.72 | $586K | No | Form 4 ↗ |
| 2025-11-14 | 2025-11-12 | Shah Nikita Executive Vice President | SSale | −132K | $11.92 | $1.57M | No | Form 4 ↗ |
| 2025-11-14 | 2025-11-12 | Shah Nikita, Executive Vice President | MExercise | +95.5K | $2.75 | $263K | No | Form 4 ↗ |
| 2025-11-14 | 2025-11-12 | Shah Nikita, Executive Vice President | MExercise | +36.3K | $2.75 | $99.9K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also AMRX’s full analysis or the market-wide insider trading feed. The tabs above jump to AMRX’s other SEC data.
Source: SEC Form 4 filings for AMRX, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.